News
Men receiving tirzepatide showed greater reductions in body weight and waist circumference and improvements in erectile ...
Baseline BMI may play a significant role in improving exercise capacity, body weight and BP among patients with HF with ...
Obesity has become a global epidemic, contributing to a host of chronic health conditions such as type 2 diabetes, hypertension, and cardiovascular ...
In a recent study published in Life Metabolism, researchers at Fudan University report that even after stopping the anti-obesity drug tirzepatide, ...
Costa Rica: A recent systematic review published in the Cureus Journal of Medical Science has shed light on the potential of ...
Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type 2 diabetes.
2h
News-Medical.Net on MSNCan one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonists
Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...
9h
Flow Space on MSNIs This the Secret to Maintaining a Healthy Weight in Menopause?
Menopause can feel like one big balancing act. Between managing your hormone levels and symptoms like hot flashes, night ...
Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...
Willingness to try new drugs for obesity management have propelled the growth of this market, which today is almost five ...
Patients put on weight loss drugs like Ozempic and Wegovy may start regaining weight within weeks of discontinuing them, a ...
Explore how semaglutide and tirzepatide may protect against dementia and stroke—keep reading for clinical implications and evidence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results